| Institution | PI Name | Title |
|---|
| Allied Innovative Systems, LLC | Simon Bystryak | Rapid detection of food borne pathogenic bacteria |
| Apath, LLC | Paul Olivo | Molecular tools for Bunyavirus antiviral screening |
| Apath, LLC | Paul Olivio | Replicon-based screening for inhibitors of alphaviruses |
| Avanir Pharmaceuticals | Angray Kang | Human Antibodies for Exposure/Protection from Anthrax |
| Biorexis Pharmaceutical Corporation | James Ballance | A Broad, Long Acting Inhibitor of Botulinum Neurotoxin |
| Bioscale, Inc. | Alexis Sauer-Budge | Pathogen Biosensor Array for Syndrome-Based Diagnostics |
| Cellerant Therapeutics, Inc. | Timothy Fong | Expansion of HSC for rescue in biodefense applications |
| Cellex, Inc. | Xing-Xiang Ling | A Rapid, Sensitive and Fully Automated Y. pestis Test |
| Core Microsolutions | Chang-Jin Kim | In toto Handheld Bioagent Detector by Digital Fluidics |
| Dakota Technologies, Inc. | Kirk Hartel | Multiplex DNA Detection Without Fluorophore Labeling |
| Delsite Biotechnologies, Inc. | Yawei Ni | An in-situ gelling nasal vaccine delivery platform |
| EIC Laboratories, Inc. | Michael Wilson | Rapid Immunoassays for Detecting Pathogenic Bacteria |
| Emetagen, LLC | Robert Goodman | Discovery of Anti-Bioweapon Agents in BAC Librarie |
| Epivac, Inc. | Anne De Groot | A Genome-Derived, Epitope-Driven Tularemia Vaccine |
| Eragen Biosciences, Inc. | James Prudent | Rapid Detection of Agents that Cause Respiratory Disease |
| Eragen Biosciences, Inc. | James Prudent | Rapid Turn-arround Multiplex Testing: Bioweapon Agents |
| Genomics USA, Inc. | Rahul Mitra | Population-scale HLA typing for home land defense |
| Hawaii Biotech, Inc. | Axel Lehrer | Recombinant Subunit Vaccine for Tick-Borne Encephalitis |
| Hawaii Biotech, Inc. | Alan McClelland | Inhibitors of Anthrax Lethal Factor Metalloproteinase |
| Hemocleanse, Inc. | Stephen Ash | Pheresis Treatment of Bioterrorism-Induced Sepsis |
| Hepadnavirus Testing, Inc. | Patricia Marion | New broad-spectrum antivirals: target bunyaviruses |
| Immport Therapeutics, Inc. | Philip Felgner | Vaccinia Proteome Affinity Reagents From Phage Display |
| Indevr, LLC | Kathy Rowlen | Advanced Detection Technologies for Biochips |
| Innoject, Inc. | Richard Gillespie | Influenza Self-Administration Vaccine System |
| Innovative Biologics, Inc. | Vladmimir Karginov | Small Molecule Blockers of B. anthracis Toxin |
| Integral Molecular | Eva Harris | Dengue Reporter Virus Particle Neutralization Assay |
| Iogenetics, LLC | Michael Imboden | Antibody-Biocide Fusions to Control Cryptosporidium |
| L2 Diagnostics, LLC | Raymond Koski | Antibody Prophylaxis and Therapy of Flavivirus Infection |
| Ligocyte Pharmaceuticals | Aiyappa Palecanda | Anthrax Vaccine Formulations Combining PA/Spore Epitopes |
| Lpath Therapeutics, Inc. | Roger Sabbadini | Therapeutic Approach to Sulfur Mustard Exposure |
| Macrogenics, Inc. | Stacy Ferguson | Development of Novel Brucella Vaccine Candidates |
| Microbiotix, Inc. | Donald Moir | Discovery of B. pseudomallei Therapeutics for Biodefense |
|
| Molecular Express, Inc. | William Ernst | Universal Influenza Matrix 2 Subunit Vaccine |
| Molecular Therapeutics, Inc. | Prasad Sunkara | Hexa-D-Arg: A Furin Inhibitor for Anthrax Biodefense |
|
| Molsoft, LLC | Maxim Totrov | Rational Design of Inhibitors of Yersinia pestis EF-Tu |
| Neurobiotex, Inc. | Christopher Frederickson | High-Speed Microfluidic Sorting of Biohazardous Cells |
| Neurome, Inc | David Lo | Adjuvants for Mucosal Immunity |
| Neurome, Inc | David Lo | FAE specific receptors for targeted vaccine delivery |
| Nexbio, Inc | Fang Fang | Identifying Broad-Spectrum Influenza Virus Inhibitors |
| Nexbio, Inc | Fang Fang | Novel Therapeutics for Pandemic and Epidemic Flu |
| Nexbio, Inc. | Mang Yu | Broad-Spectrum Therapeutics for Influenza |
| Nomadics | Jean Clarke | Polymer-Based Yersinia Pestis Point-of-Case Diagnostics |
| Novobiotic Pharmaceuticals | Losee Ling | Developing Novel Antibiotics Against Yersinia pestis |
| Origen Therapeutics | Philip Leighton | Human immunotherapeutics for Biodefense Applications |
| Paratek Pharmaceuticals | Michael Alekshun | Novel Therapeutics for Biodefense |
| Polymedix, Inc. | Richard Scott | Biomimetic antimicrobials for biowarfare pathogens |
| Protein Potential, LLC | Kim Lee Sim | A Tetravalent Dengue Recombinanat Protein Vaccine |
| Redstorm Scientific, Inc. | Steven Whitten | Antiviral Agents directed at West Nile Virus |
| Sensor Technologies, Inc. | David Wolf | Improved Pathogen Detection by Fluorescence Correlation |
| Seralogix | Kenneth Drake | BWA Host-Pathogen Innate Immune S/W Analysis Tools |
| Siga Technologies, Inc. | Dennis Hruby | Antiviral Drugs for Category A Arenavirus |
| Siga Technologies, Inc. | Dennis Hruby | Small Molecule Inhibitors of Smallpox Virus Replication |
| Techlab, Inc. | David Lyerly | New Diagnostics for Amebiasis |
| Transtech Pharma, Inc. | Murty Arimilli | Novel Orthopox Small Molecule Anti-Virals |
| TSRL, Inc. | John Hilfinger | Improving Absorption and Targeting of Antiviral Drugs |
| Vaccinex, Inc. | Ernest Smith | Human Monoclonal Antibodies for Bioterrorism Defense |
| Vaxinnate Corporation | Thomas Powell | Discovery of Novel TLR Ligands with Adjuvant Properties |